Randomized Controlled Trial
Copyright ©The Author(s) 2024.
World J Hepatol. Dec 27, 2024; 16(12): 1458-1467
Published online Dec 27, 2024. doi: 10.4254/wjh.v16.i12.1458
Table 1 Baseline characteristics of enrolled patients with liver cirrhosis and healthy controls
Variable
Healthy control subjects
Liver cirrhosis patients
P value
Participants (n)3070-
Age (year)53 ± 6.256.1 ± 5.10.199
Women, n (%)14 (46.7)31 (44.3)0.826
BMI (kg/m2)24.8 ± 4.122.5 ± 3.70.413
Energy intake (kcal/day)2443 ± 4732264 ± 6420.031
TBW (L)40.04 ± 6.6740.25 ± 9.380.221
ICW (L)26.84 ± 6.3625.62 ± 6.320.316
ECW (L)14.81 ± 2.5014.63 ± 3.410.332
TBP (kg)10.91 ± 1.8011.09 ± 2.730.153
Mineral (kg)3.67 ± 0.614.03± 1.070.341
BFM (kg)21.27 ± 6.7414.38 ± 6.63< 0.001
SMM (kg)33.91 ± 5.4921.42 ± 8.22< 0.001
FFM (kg)54.63 ± 3.0848.02 ± 3.85< 0.001
PBF (%)27.77 ± 7.5020.37 ± 8.130.227
WHR0.90 ± 0.050.83 ± 0.140.612
VFA (cm2)95.61 ± 3.7866.32 ± 3.50< 0.001
BCM (kg)36.16 ± 3.0431.72 ± 2.02< 0.001